BtX — Breakthrough device

A device introducing a high degree of novelty in its technology, the related clinical procedure, or its application in clinical practice, and expected to deliver a significant positive clinical impact for a life-threatening or irreversibly debilitating disease — either against available alternatives and the state of the art, or by meeting an unmet medical need. A guidance concept rather than a defined legal status.

Reference: MDCG 2025-9

Previous
Previous

Borderline product

Next
Next

CA — Competent authority